Trial Profile
Follow-up Study of Safety and Efficacy in Subjects Who Completed NEUROSTEM Phase-I/IIa Clinical Trial
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 16 Mar 2023
Price :
$35
*
At a glance
- Drugs Mesenchymal stem cell therapy (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors Medipost
- 13 Mar 2023 Status changed from recruiting to completed.
- 06 Jun 2017 New trial record